Your AI-Trained Oncology Knowledge Connection!

Evolving Treatments in Hepatocellular Carcinoma: Updates from ASCO GI 2024 : Episode 14

Opinion

Video

April 8, 2024

CARES-310 Trial: Impressions and Clinical Impact on HCC Treatment Landscape

Key opinion leaders share their takeaways from the CARES-310 trial and its impact on their treatment approach in HCC management.

EP: 1.Hepatocellular Carcinoma (HCC) Disease State Overview

EP: 2.Utilizing Interventional Radiology and Liver-directed Therapies

EP: 3.Determining Transarterial Chemoembolization (TACE) Candidacy for Patients with HCC

EP: 4.EMERALD-1 Study: Significance as Presented at ASCO GI 2024

EP: 5.EMERALD-1 Study: Outshining Negative Clinical Trials Based Upon TKI- and Liver-directed Therapies

EP: 6.IMBrave-050 Study Overview

EP: 7.Patient Profile 1: Advanced HCC Treated with Durvalumab and Tremelimumab

EP: 8.HIMALAYA Study in Advanced Stage HCC

EP: 9.Establishing Optimal HCC Treatment Strategy

EP: 10.IMBrave150 Study Overview

EP: 11.HCC Treatment Strategy Driven by Real-World Evidence

EP: 12.Combining Liver-directed and Systemic Therapies in HCC

EP: 13.Patient Profile 2: Patient Progression After Frontline HCC Therapy

Now Viewing

EP: 14.CARES-310 Trial: Impressions and Clinical Impact on HCC Treatment Landscape

EP: 15.REGONEXT Study: Driving Second-line HCC Treatment Strategy

EP: 16.Trajectory of Evolving HCC Treatment Landscape

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

Latest CME

View All

Video

Addressing Unmet Needs in HER2+ Metastatic BTC

Apr 24th 2025 - Apr 25th 2026

online-activity

Video

Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2

Apr 23rd 2025 - Apr 24th 2026

online-activity

Video

(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments

Apr 23rd 2025 - Apr 24th 2026

online-activity

Latest Conference Coverage

Dr Hanna on Elraglusib Plus Chemotherapy and Immunotherapy in Advanced Salivary Gland Cancer

Dr Scilipoti on the Value of Life Expectancy Assessments to Guide Prostate Cancer Treatment Strategies

Dr Guerrero-Ramos on the Potential Role of TAR-200 in BCG-Unresponsive Papillary NMIBC

Subgroup Data From ARANOTE Highlight rPFS Benefit of Darolutamide Plus ADT in Black Patients With mHSPC

View More Latest Conference Coverage

Advertise

About OncLive

Editorial Board

MJH Life Sciences brands

Privacy

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

CARES-310 Trial: Impressions and Clinical Impact on HCC Treatment Landscape

EP: 1.Hepatocellular Carcinoma (HCC) Disease State Overview

EP: 2.Utilizing Interventional Radiology and Liver-directed Therapies

EP: 3.Determining Transarterial Chemoembolization (TACE) Candidacy for Patients with HCC

EP: 4.EMERALD-1 Study: Significance as Presented at ASCO GI 2024

EP: 5.EMERALD-1 Study: Outshining Negative Clinical Trials Based Upon TKI- and Liver-directed Therapies

EP: 6.IMBrave-050 Study Overview

EP: 7.Patient Profile 1: Advanced HCC Treated with Durvalumab and Tremelimumab

EP: 8.HIMALAYA Study in Advanced Stage HCC

EP: 9.Establishing Optimal HCC Treatment Strategy

EP: 10.IMBrave150 Study Overview

EP: 11.HCC Treatment Strategy Driven by Real-World Evidence

EP: 12.Combining Liver-directed and Systemic Therapies in HCC

EP: 13.Patient Profile 2: Patient Progression After Frontline HCC Therapy

EP: 14.CARES-310 Trial: Impressions and Clinical Impact on HCC Treatment Landscape

EP: 15.REGONEXT Study: Driving Second-line HCC Treatment Strategy

EP: 16.Trajectory of Evolving HCC Treatment Landscape

Newsletter

Latest CME

(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Addressing Unmet Needs in HER2+ Metastatic BTC

Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2

(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Addressing Unmet Needs in HER2+ Metastatic BTC

Optimizing Today and Looking to Tomorrow in Metastatic CRPC—Homing in on EZH2

(CME Track) Clinical Consultations™: Framing a New Approach to Geographic Atrophy Management – Expert Insights into Recent Developments

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Latest Conference Coverage